Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Feb 12, 2018
Digital Spatial Profiling Demonstrates Profiling of Proteins and 1,000+ mRNAs Across Multiple Regions from FFPE Tissue Sections using Next Generation Sequencing Readout First Customer Data Using Hyb & Seq Single Molecule Sequencing Demonstrates Potential Utility in Oncology and Infectious Disease SEATTLE, Feb. 12, 2018 (GLOBE NEWSWI...
Feb 5, 2018
Comprehensive Study Includes All Danish Women Diagnosed with Breast Cancer from 2000 to 2003 who were Indicated for Prosigna and Treated with Endocrine Therapy Accompanying Editorial Highlights Encouraging Data on Clinical Utility in Node-Positive Breast Cancer SEATTLE, Feb. 05, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NA...
Jan 19, 2018
SEATTLE, Jan. 19, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Thomas Bailey, NanoString's new Chief Financial Officer. In accordance wit...
Jan 16, 2018
SEATTLE, Jan. 16, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Thomas Bailey has been appointed chief financial officer, effective January 16, 2018.    Mr. Bailey brings to NanoString more than 20 years...
Jan 8, 2018
SEATTLE, Jan. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the fourth quarter and fiscal year ended December 31, 2017. Financial Highlights: Product and ...
Jan 4, 2018
SEATTLE and TOKYO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Riken Genesis, a subsidiary of Sysmex Corporation (TOKYO, 6869), today announced that they have entered into a partnership to  introduce nCounter-based...
Dec 7, 2017
More than 45 Abstracts Highlight the Value of the nCounter Platform in Hematology, including 11 that Demonstrate the Potential Clinical Utility of the Lymphoma Subtyping Test Company Announces Launch of Vantage 3D DNA:RNA:Protein Hematology Assays SEATTLE, Dec. 07, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a prov...
Nov 9, 2017
45 Abstracts Demonstrate the Value of the nCounter Platform for Immuno-Oncology Research Studies Indicate the Clinical Relevance of the Tumor Inflammation Signature for Multiple Immunotherapies SEATTLE, Nov. 09, 2017 (GLOBE NEWSWIRE) --  NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational researc...
Nov 2, 2017
SEATTLE, Nov. 02, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the third quarter of 2017. The results were consistent with the company's announcement of preliminary revenue on October 11, 201...
Oct 26, 2017
SEATTLE and PITTSBURGH, Oct. 26, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and the NSABP Foundation, Inc. (NSABP), an academic research organization supported by the National Cancer Institute (NCI) and industry funding, today...
Oct 11, 2017
SEATTLE, Oct. 11, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced preliminary total revenue of approximately $25.9 million to $26.9 million for the third quarter, including product and service revenue of approximate...
Sep 18, 2017
SEATTLE, Sept. 18, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company has demonstrated the capability of its Hyb & Seq technology to perform liquid biopsy measurement.  The proof-of-principle work was ...
Sep 7, 2017
SEATTLE, Sept. 07, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will webcast the company's presentation at the 2017 Morgan Stanley Global Healthcare Conference in New York City, on Tuesday, September 12, ...
Sep 5, 2017
SEATTLE, Sept. 05, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Anthem has issued a positive coverage decision for the Prosigna® Breast Cancer Gene Signature Assay.  This positive coverage decision is i...
Aug 31, 2017
SEATTLE, Aug. 31, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will webcast the company's presentation at the 2017 Baird Global Healthcare Conference in New York City, on Thursday, September 7, 2017. ...
Page:
...
Next Last
 
= add file to Briefcase